Beta Bionics, Inc. Common Stock BBNX Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$73.2M-33.7% | -$54.76M-24.2% | ||
| $1.57M+36.7% | $1.15M-6.1% | ||
| $16.38M+157% | $6.38M+12.8% | ||
| -$50.93M-5.5% | -$48.27M-48.8% | ||
| $5.3M+56.0% | $3.4M+745% | ||
| —— | -$3.48M+95.0% | ||
| $214.87M+286% | $55.62M-45.0% | ||
| —— | $3.87M+449% | ||
| -$56.22M-8.8% | -$51.67M-57.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beta Bionics, Inc. Common Stock generate?
- Beta Bionics, Inc. Common Stock (BBNX) generated -$54.8M in operating cash flow over the trailing twelve months.
- What is Beta Bionics, Inc. Common Stock's free cash flow?
- After $6.3M of capital expenditures, Beta Bionics, Inc. Common Stock's free cash flow was -$61.1M over the trailing twelve months, down 2.9% year over year.
- Where does Beta Bionics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
